Approval · Notice of Compliance 22975 · 2019
CARIPUL: Notice of Compliance 22975
Issued December 3, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22975
- Date
- December 3, 2019
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To add an alternate drug product manufacturing, testing and packaging site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CARIPUL | Not yet assigned | — |
Medicinal ingredients
- EPOPROSTENOL SODIUM 1.5 MG per VIAL